The enrichment of C0 FXYD5+ TCs in cancer tissues and their association with poor prognosis confirmed previous studies that FXYD5 expression is associated with increased epithelial-mesenchymal transition (EMT) and metastatic potential (89, 90). Here, FXYD5 is linked to cancer.